Tess Pollinger, D.O,
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,659 | 330 | 92.9% |
| Education | $432.83 | 5 | 7.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,845 | 123 | $0 (2024) |
| Janssen Biotech, Inc. | $1,630 | 92 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $388.93 | 21 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $332.51 | 15 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $287.79 | 10 | $0 (2024) |
| Celgene Corporation | $227.76 | 12 | $0 (2019) |
| Lilly USA, LLC | $208.42 | 9 | $0 (2024) |
| GENZYME CORPORATION | $145.48 | 6 | $0 (2024) |
| PFIZER INC. | $136.09 | 7 | $0 (2024) |
| Incyte Corporation | $126.71 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,376 | 52 | ABBVIE INC. ($422.07) |
| 2023 | $1,039 | 68 | Janssen Biotech, Inc. ($325.32) |
| 2022 | $1,576 | 98 | ABBVIE INC. ($674.41) |
| 2021 | $775.19 | 53 | AbbVie Inc. ($187.95) |
| 2020 | $286.30 | 16 | Janssen Biotech, Inc. ($166.42) |
| 2019 | $585.84 | 30 | Celgene Corporation ($191.89) |
| 2018 | $453.19 | 18 | Novartis Pharmaceuticals Corporation ($167.34) |
All Payment Transactions
335 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $19.35 | General |
| 11/05/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Inflammation | ||||||
| 10/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.03 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: DERMATOLOGY | ||||||
| 10/15/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $29.41 | General |
| Category: DERMATOLOGY | ||||||
| 10/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $107.41 | General |
| Category: Immunology | ||||||
| 10/01/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $39.47 | General |
| Category: ONCOLOGY | ||||||
| 09/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $5.68 | General |
| Category: Immunology | ||||||
| 09/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $5.04 | General |
| Category: Immunology | ||||||
| 09/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.90 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.67 | General |
| Category: IMMUNOLOGY | ||||||
| 09/05/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $28.79 | General |
| Category: Dermatology | ||||||
| 08/27/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: Immunology | ||||||
| 08/22/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Dermatology | ||||||
| 08/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $5.93 | General |
| Category: Immunology | ||||||
| 08/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.95 | General |
| Category: IMMUNOLOGY | ||||||
| 07/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.71 | General |
| Category: Immunology | ||||||
| 07/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $80.86 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: IMMUNOLOGY | ||||||
| 07/16/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: DERMATOLOGY | ||||||
| 07/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.57 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $5.89 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 904 | 1,374 | $145,234 | $67,313 |
| 2022 | 13 | 1,189 | 1,953 | $257,364 | $84,346 |
| 2021 | 15 | 1,200 | 1,827 | $245,921 | $85,001 |
| 2020 | 11 | 844 | 1,290 | $147,996 | $47,428 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 200 | 217 | $28,892 | $13,704 | 47.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 135 | 150 | $26,127 | $12,431 | 47.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 102 | 127 | $23,621 | $11,860 | 50.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 140 | 156 | $17,766 | $5,956 | 33.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 46 | 46 | $11,280 | $5,670 | 50.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 37 | 43 | $11,556 | $5,579 | 48.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 57 | 57 | $9,107 | $4,482 | 49.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 52 | 55 | $7,752 | $3,662 | 47.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 102 | 488 | $6,360 | $2,523 | 39.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 33 | 35 | $2,774 | $1,446 | 52.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 302 | 384 | $55,680 | $22,096 | 39.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 172 | 203 | $45,878 | $15,797 | 34.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 94 | 110 | $23,980 | $9,707 | 40.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 193 | 230 | $40,152 | $8,142 | 20.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 43 | 61 | $21,655 | $7,123 | 32.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 72 | 76 | $10,868 | $4,655 | 42.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 62 | 62 | $13,330 | $4,217 | 31.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 40 | 40 | $13,240 | $3,851 | 29.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 134 | 675 | $18,648 | $3,249 | 17.4% |
| 67850 | Destruction of growth of eyelid margin, 1.0 cm or less | Office | 2022 | 18 | 18 | $7,830 | $2,769 | 35.4% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2022 | 18 | 19 | $3,610 | $1,550 | 42.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 26 | 27 | $2,349 | $1,149 | 48.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 15 | 48 | $144.00 | $40.38 | 28.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 259 | 317 | $45,827 | $18,682 | 40.8% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 174 | 200 | $45,053 | $15,891 | 35.3% |
About Tess Pollinger, D.O,
Tess Pollinger, D.O, is a Student in an Organized Health Care Education/Training Program healthcare provider based in Albany, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2012. The National Provider Identifier (NPI) number assigned to this provider is 1598020273.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Tess Pollinger, D.O, has received a total of $6,092 in payments from pharmaceutical and medical device companies, with $1,376 received in 2024. These payments were reported across 335 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($5,659).
As a Medicare-enrolled provider, Pollinger has provided services to 4,137 Medicare beneficiaries, totaling 6,444 services with total Medicare billing of $284,088. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Dermatology
- Location Albany, NY
- Active Since 07/10/2012
- Last Updated 01/11/2024
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1598020273
Products in Payments
- TREMFYA (Drug) $1,449
- SKYRIZI (Biological) $1,190
- DUPIXENT (Biological) $326.87
- Otezla (Drug) $318.79
- RINVOQ (Biological) $297.22
- COSENTYX (Biological) $268.40
- TALTZ (Drug) $208.42
- Tremfya (Drug) $187.01
- ILUMYA (Biological) $138.66
- Skyrizi (Biological) $128.34
- OPZELURA (Drug) $126.71
- Humira (Biological) $120.00
- EUCRISA (Drug) $115.11
- REMICADE (Biological) $113.98
- HUMIRA (Biological) $110.18
- LIBTAYO (Biological) $85.40
- Ilumya (Biological) $83.80
- Sotyktu (Drug) $81.86
- ADBRY (Biological) $74.24
- AKLIEF (Drug) $73.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Albany
Anuj Malhotra, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $224,738
Dr. Erica Parrotta, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $111,723
William Raible, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $42,671
Dr. Olumayowa Abiodun, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $33,199
Dr. Alexandra Paul, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $15,462
Dr. Sridhar Musuku, M.d Frca, M.D FRCA
Student in an Organized Health Care Education/Training Program — Payments: $14,736